FDA Guidance Clarifies Agency Regs v. Revised Common Rule

International Pharmaceutical Regulatory Monitor
A A
The FDA released new guidance on how researchers can comply with both agency regulations and pending Common Rule revisions that protect human subjects in clinical trials.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00